{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T15:32:50Z","timestamp":1793201570801,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.clineuro.2020.105741","type":"journal-article","created":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T11:34:05Z","timestamp":1581939245000},"page":"105741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Randomized control trial of evaluation of Clemastine effects on visual evoked potential, nerve fiber layer and ganglion cell layer complex in patients with optic neuritis"],"prefix":"10.1016","volume":"193","author":[{"given":"Mehdi","family":"Moghaddasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Nabovvati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"koushki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Soltansanjari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Sardarinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9701-7516","authenticated-orcid":false,"given":"Nafise","family":"Mohebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedhossein","family":"Rabani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.clineuro.2020.105741_bib0005","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00415-014-7266-2","article-title":"Is the incidence of optic neuritis rising? Evidence from an epidemiological study in Barcelona (Spain), 2008-2012","volume":"261","author":"Martinez-Lapiscina","year":"2014","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.clineuro.2020.105741_bib0010","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(13)70259-X","article-title":"Optic neuritis","volume":"13","author":"Toosy","year":"2014","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.clineuro.2020.105741_bib0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1212\/WNL.0b013e31827b1a1c","article-title":"Active MS is associated with accelerated retinal ganglion cell\/inner plexiform layer thinning","volume":"80","author":"Ratchford","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2020.105741_bib0020","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.18246","article-title":"Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery","volume":"5","author":"Mei","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.clineuro.2020.105741_bib0025","series-title":"Accelerated Remyelination During Inflammatory Demyelination Prevents Axonal Loss and Improves Functional Recovery","first-page":"5","author":"Mei","year":"2016"},{"issue":"8","key":"10.1016\/j.clineuro.2020.105741_bib0030","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/nm.3618","article-title":"Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis","volume":"20","author":"Mei","year":"2014","journal-title":"Nat. Med."},{"issue":"10111","key":"10.1016\/j.clineuro.2020.105741_bib0035","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/S0140-6736(17)32346-2","article-title":"Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial","volume":"390","author":"Green","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.clineuro.2020.105741_bib0040","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.clineuro.2020.105741_bib0045","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1474-4422(16)30377-5","article-title":"Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial","volume":"16","author":"Cadavid","year":"2017","journal-title":"Lancet Neurol."},{"issue":"318","key":"10.1016\/j.clineuro.2020.105741_bib0050","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/01621459.1967.10482916","article-title":"On the Kolmogorov-Smirnov test for normality with mean and variance unknown","volume":"62","author":"Lilliefors","year":"1967","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.clineuro.2020.105741_bib0055","series-title":"Paired t Test. Wiley encyclopedia of clinical trials","first-page":"1","author":"Hsu","year":"2007"},{"issue":"6","key":"10.1016\/j.clineuro.2020.105741_bib0060","doi-asserted-by":"crossref","first-page":"46-","DOI":"10.15844\/pedneurbriefs-29-6-5","article-title":"Prognostic factors of MS conversion in optic neuritis","volume":"29","author":"Fajardo","year":"2015","journal-title":"Pediatr. Neurol. Briefs"},{"issue":"12","key":"10.1016\/j.clineuro.2020.105741_bib0065","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/nrneurol.2017.139","article-title":"Achievements and obstacles of remyelinating therapies in multiple sclerosis","volume":"13","author":"Stangel","year":"2017","journal-title":"Nat. Rev. Neurol."},{"issue":"10","key":"10.1016\/j.clineuro.2020.105741_bib0070","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nrn3550","article-title":"Pathophysiology of the brain extracellular matrix: a new target for remyelination","volume":"14","author":"Lau","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"issue":"11","key":"10.1016\/j.clineuro.2020.105741_bib0075","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nrneurol.2012.200","article-title":"Neuroprotection and repair in multiple sclerosis","volume":"8","author":"Franklin","year":"2012","journal-title":"Nat. Rev. Neurol."},{"issue":"3","key":"10.1016\/j.clineuro.2020.105741_bib0080","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1523\/JNEUROSCI.3608-15.2016","article-title":"Clemastine enhances myelination in the prefrontal cortex and rescues behavioral changes in socially isolated mice","volume":"36","author":"Liu","year":"2016","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.clineuro.2020.105741_bib0085","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/dneu.20976","article-title":"Muscarinic receptor subtypes as potential targets to modulate oligodendrocyte progenitor survival, proliferation, and differentiation","volume":"72","author":"De Angelis","year":"2012","journal-title":"Dev. Neurobiol."},{"issue":"5","key":"10.1016\/j.clineuro.2020.105741_bib0090","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s12264-015-1555-3","article-title":"Clemastine rescues behavioral changes and enhances remyelination in the cuprizone mouse model of demyelination","volume":"31","author":"Li","year":"2015","journal-title":"Neurosci. Bull."},{"issue":"1","key":"10.1016\/j.clineuro.2020.105741_bib0095","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/brain\/awx312","article-title":"Clemastine rescues myelination defects and promotes functional recovery in hypoxic brain injury","volume":"141","author":"Cree","year":"2017","journal-title":"Brain"},{"issue":"13","key":"10.1016\/j.clineuro.2020.105741_bib0100","first-page":"5780-","article-title":"Retinal ganglion cell layer thinning and vision outcome in NAION and optic neuritis over six months","volume":"55","author":"Wang","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6","key":"10.1016\/j.clineuro.2020.105741_bib0105","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/01.icu.0000188705.67815.0e","article-title":"Optical coherence tomography: measuring in-vivo axonal survival and neuroprotection in multiple sclerosis and optic neuritis","volume":"16","author":"Sergott","year":"2005","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"2","key":"10.1016\/j.clineuro.2020.105741_bib0110","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ophtha.2005.10.040","article-title":"Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis","volume":"113","author":"Fisher","year":"2006","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.clineuro.2020.105741_bib0115","first-page":"277","article-title":"An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography","volume":"131","author":"Henderson","year":"2007","journal-title":"Brain."},{"issue":"6","key":"10.1016\/j.clineuro.2020.105741_bib0120","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/pr.2018.45","article-title":"Clemastine effects in rat models of a myelination disorder","volume":"83","author":"Turski","year":"2018","journal-title":"Pediatr. Res."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846720300846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846720300846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:31:22Z","timestamp":1759588282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846720300846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":24,"alternative-id":["S0303846720300846"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2020.105741","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized control trial of evaluation of Clemastine effects on visual evoked potential, nerve fiber layer and ganglion cell layer complex in patients with optic neuritis","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2020.105741","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105741"}}